Guideline Perspectives on Metformin in 2026 Leading organizations such as the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) still recommend metformin as a first-line agent for most people with type 2 diabetes
13 Overall, the benefit-risk profile of anti-obesity injections, particularly GLP-1 receptor agonists, remains favorable for many patients with obesity
Prescription weight loss options
Unlimited provider check-ins bundled
Plus, GLP-1s are believed to dampen dopamine signaling, which might actually put the lid on initiative and drive and competitiveness, Ziyad Al-Aly, a researcher at Washington University in St
Mechanisms of Action and Therapeutic Application of GLP-1 and GIP. Cell Metabolism